ES2136954T3 - Utilizacion de al menos un agua termal de vichy como antagonista de sustancia p. - Google Patents

Utilizacion de al menos un agua termal de vichy como antagonista de sustancia p.

Info

Publication number
ES2136954T3
ES2136954T3 ES96401783T ES96401783T ES2136954T3 ES 2136954 T3 ES2136954 T3 ES 2136954T3 ES 96401783 T ES96401783 T ES 96401783T ES 96401783 T ES96401783 T ES 96401783T ES 2136954 T3 ES2136954 T3 ES 2136954T3
Authority
ES
Spain
Prior art keywords
thermal water
substance
vichy
substance antagonist
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96401783T
Other languages
English (en)
Inventor
Lionel Breton
Jacques Leclaire
Lacharriere Olivier De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2136954T3 publication Critical patent/ES2136954T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/08—Mineral waters; Sea water
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A LA UTILIZACION DE AL MENOS UN AGUA TERMAL DE LA CUENCA DE VICHY EN UNA COMPOSICION COSMETICA COMO ANTAGONISTA DE SUSTANCIA P. LA INVENCION SE REFIERE TAMBIEN A LA UTILIZACION DE AL MENOS UN AGUA TERMAL DE LA CUENCA DE VICHY PARA LA PREPARACION DE UNA COMPOSICION FARMACEUTICA, MAS EN PARTICULAR DERMATOLOGICA, DESTINADA A TRATAR LOS TRASTORNOS ASOCIADOS A UN EXCESO DE SINTESIS Y/O DE LIBERACION DE SUSTANCIA P.
ES96401783T 1995-09-19 1996-08-13 Utilizacion de al menos un agua termal de vichy como antagonista de sustancia p. Expired - Lifetime ES2136954T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9510976A FR2738742B1 (fr) 1995-09-19 1995-09-19 Utilisation d'au moins une eau thermale de vichy en tant qu'antagoniste de substance p

Publications (1)

Publication Number Publication Date
ES2136954T3 true ES2136954T3 (es) 1999-12-01

Family

ID=9482700

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96401783T Expired - Lifetime ES2136954T3 (es) 1995-09-19 1996-08-13 Utilizacion de al menos un agua termal de vichy como antagonista de sustancia p.

Country Status (5)

Country Link
US (1) US6106846A (es)
EP (1) EP0764440B1 (es)
DE (1) DE69603239T2 (es)
ES (1) ES2136954T3 (es)
FR (1) FR2738742B1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6468552B1 (en) * 2000-06-02 2002-10-22 Neutrogena Corporation Stabilized compositions containing oxygen-labile active agents
US6630175B1 (en) 2000-06-29 2003-10-07 Johnson & Johnson Consumer Companies, Inc. Method of reducing eye irritation
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US6432424B1 (en) 2000-06-29 2002-08-13 Johnson & Johnson Consumer Companies, Inc. Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
US6372791B1 (en) 2000-06-29 2002-04-16 Johnson & Johnson Consumer Companies, Inc. Method of promoting skin cell metabolism
DE60007103T2 (de) * 2000-06-29 2004-09-16 Johnson & Johnson Consumer Companies, Inc. Verfahren zur Förderung der Aufnahme von Nährstoffen, Wasser und/oder Sauerstoff in die Haut
GB2474041A (en) * 2009-10-02 2011-04-06 Omorovicza Cosmetics Ltd Cosmetic composition comprising thermal mineral water
AU2014324694B2 (en) * 2013-09-30 2017-06-29 Elc Management Llc Watery lotion skin care compositions and methods
FR3038839B1 (fr) * 2015-07-13 2020-04-24 Clinique Des Celestins Eau de vichy pour moduler la croissance bacterienne
CN110856695A (zh) * 2018-08-24 2020-03-03 伽蓝（集团）股份有限公司 一种温泉水在化妆品中的应用
FR3115696B1 (fr) * 2020-11-05 2023-06-16 Oreal Association d’une eau thermale de Vichy et d’un extrait d’au moins une bactérie de l’espèceVitreoscilla filiformis cultivée sur un milieu comprenant au moins une eau thermale de Vichy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1243957A (en) * 1983-06-03 1988-11-01 Laszlo Bogdany Compositions for cosmetic, health- and body- preserving use
FR2668063A1 (fr) * 1990-10-17 1992-04-24 Fabre Pierre Cosmetique Liposomes d'eaux thermales stabilises dans un gel d'adn.
EP1082959A1 (en) * 1991-09-20 2001-03-14 Glaxo Group Limited NK1 Antagonists for the treatment of depression
FR2712492B1 (fr) * 1993-11-16 1996-02-09 Fabre Pierre Cosmetique Compositions cosmétiques à base d'eaux thermales et leur procédé de préparation.
FR2722691A1 (fr) * 1994-07-22 1996-01-26 Oreal Composition cosmetique et/ou dermatologique conten lutter contre l'acne ou le vieillissement ant de l'eau thermale ou minerale et un actif pour
FR2728165A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2728169A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
FR2728265A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p dans une composition pharmaceutique

Also Published As

Publication number Publication date
DE69603239T2 (de) 1999-11-11
FR2738742B1 (fr) 1997-11-14
FR2738742A1 (fr) 1997-03-21
EP0764440B1 (fr) 1999-07-14
DE69603239D1 (de) 1999-08-19
EP0764440A1 (fr) 1997-03-26
US6106846A (en) 2000-08-22

Similar Documents

Publication Publication Date Title
ES2081110T3 (es) Composicion cosmetica o farmaceutica, particularmente dermatologica, destinada a favorecer la pigmentacion de la piel o de los cabellos, que contiene un extracto de cyperus y su procedimiento de fabricacion.
ES2159382T3 (es) Compuestos estilbenicos con grupo adamantilo, composiciones que los contienen y utilizaciones.
ES2120274T3 (es) Utilizacion de un extracto de una bacteria filamentosa no fotosintetica y composicion.
ES2176700T3 (es) Composiciones para la piel.
BRPI0414800A (pt) composições de higiene oral baseadas em morinda citrifolia e seus usos
BR9810062A (pt) Composição cosmética contendo um agente alvejante, bem como uso de uma fonte de água em combinação com a mesma
ES2171746T3 (es) Empleo de epinastina para el tratamiento de dolores.
ES2154388T3 (es) Utilizacion de un antagonista de cgrp en una composicion cosmetica, farmaceutica o dermatologica y composicion obtenida.
AR005941A1 (es) Composicion cosmetica, su uso, y procedimiento de tratamiento cosmetico de substancias queratinicas tales como el cabello empleando dicha composicion
ES2157684T3 (es) Composicion de blanqueo de la piel y/o de los cabellos.
BR0108347A (pt) Composição de cosmético
ES2178250T3 (es) Derivados de aminofenol y su utilizacionm en cosmetica.
AR019503A1 (es) Utilizacion de derivados sustituidos en 3 del estilbeno como agentes activos desodorantes en las composiciones cosmeticas
BR9914925A (pt) Processos para reduzir o crescimento de cabelo de mamìfero, para tratar uma área de pele, e, para produzir uma composição para inibir crescimento do cabelo de mamìfero, uso de um inibidor de fosfatase alcalina, e, composição usada para inibir crescimento de cabelo de mamìfero.
MX9801596A (es) Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
ES2124638T3 (es) Composicion cosmetica que comprende un polimero fijante y un almidon anfotero.
BR0114059A (pt) Derivados de resorcinol
ES2136954T3 (es) Utilizacion de al menos un agua termal de vichy como antagonista de sustancia p.
CR7608A (es) Derivados de ciclotiocarbamativa como moduladores de rp y uso de los mismos para tratamiento de trastornos de la piel
GT200100199A (es) Nuevos retinoides para el tratamiento de efisema.
AR017222A1 (es) Procedimiento de utilizacion de un agente que inhibe el desarrollo de p.ovale, en la preparacion de medicamentos
ES2158597T3 (es) Compuestos bioaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
AR004052A1 (es) Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico
AR029586A1 (es) Composiciones que comprenden compuestos del tipo de sal flavilio no sustituidos en la posicion 3 para la coloracion de la piel y utilizaciones
ES2187125T3 (es) Compuestos biciclicos-aromaticos y su utilizacion en medicina humana o veterinaria asi como en cosmetologia.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 764440

Country of ref document: ES